MENU
+Compare
OZEM
ETF ticker: NASDAQ
AS OF
Dec 4, 12:27 PM (EDT)
Price
$32.48
Change
+$0.25 (+0.78%)

OZEM stock forecast, quote, news & analysis

The investment seeks to provide capital appreciation... Show more

Category: #Health
OZEM
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for OZEM with price predictions
Dec 03, 2025

OZEM's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for OZEM moved out of overbought territory on December 01, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 10 instances where the indicator moved out of the overbought zone. In of the 10 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 02, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on OZEM as a result. In of 18 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for OZEM turned negative on December 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 13 similar instances when the indicator turned negative. In of the 13 cases the stock turned lower in the days that followed. This puts the odds of success at .

OZEM broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OZEM advanced for three days, in of 101 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 62 cases where OZEM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Market Cap

The average market capitalization across the Roundhill GLP-1 & Weight Loss ETF ETF is 108.38B. The market cap for tickers in the group ranges from 533.19M to 925.06B. LLY holds the highest valuation in this group at 925.06B. The lowest valued company is ALT at 533.19M.

High and low price notable news

The average weekly price growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 13%. For the same ETF, the average monthly price growth was 61%, and the average quarterly price growth was 647%. ROG experienced the highest price growth at 7%, while REGN experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was 29%. For the same stocks of the ETF, the average monthly volume growth was -51% and the average quarterly volume growth was 57%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 77
Price Growth Rating: 44
SMR Rating: 71
Profit Risk Rating: 72
Seasonality Score: 12 (-100 ... +100)
View a ticker or compare two or three
OZEM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details